David Campany

Ceftolozane/tazobactam for the treatment of XDR Pseudomonas aeruginosa infections

Laura Escolà‐Vergé, Carles Pigrau, Ibai Los‐Arcos et al. · Infection · 2018 · 54 citations

Antibiotics, Antimicrobial Chemotherapy, Microbiology +4

Impact of local guidelines and an integrated dispensing system on antibiotic prophylaxis quality in a surgical centre

Carme Alerany, David Campany, Josep Monterde et al. · Journal of Hospital Infection · 2005 · 47 citations

Surgical Site Infections, Surgical Quality Control, Antibiotics +12

Ceftazidime-Avibactam plus Aztreonam for the Treatment of Infections by VIM-Type-Producing Gram-Negative Bacteria

Abiu Sempere, Belén Viñado, Ibai Los‐Arcos et al. · Antimicrobial Agents and Chemotherapy · 2022 · 34 citations · Full text

Tigecycline-associated hypofibrinogenemia in a real-world setting

David Campany, María Larrosa-García, Pilar Lalueza-Broto et al. · International Journal of Clinical Pharmacy · 2020 · 33 citations

Tigecycline-associated Hypofibrinogenemia, Hematology, Neuroendocrine Disorder +3

Safety and Effectiveness of Isavuconazole Treatment for Fungal Infections in Solid Organ Transplant Recipients (ISASOT Study)

Arnau Monforte, Ibai Los‐Arcos, Marı́a Gómez et al. · Microbiology Spectrum · 2022 · 33 citations · Full text